JO Armitage

3.3k total citations
42 papers, 2.7k citations indexed

About

JO Armitage is a scholar working on Pathology and Forensic Medicine, Hematology and Genetics. According to data from OpenAlex, JO Armitage has authored 42 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pathology and Forensic Medicine, 18 papers in Hematology and 17 papers in Genetics. Recurrent topics in JO Armitage's work include Lymphoma Diagnosis and Treatment (28 papers), Hematopoietic Stem Cell Transplantation (17 papers) and Chronic Lymphocytic Leukemia Research (12 papers). JO Armitage is often cited by papers focused on Lymphoma Diagnosis and Treatment (28 papers), Hematopoietic Stem Cell Transplantation (17 papers) and Chronic Lymphocytic Leukemia Research (12 papers). JO Armitage collaborates with scholars based in United States, Germany and Türkiye. JO Armitage's co-authors include Anne Kessinger, DD Weisenburger, PJ Bierman, JM Vose, DD Weisenburger, WG Sanger, JR Anderson, Purtilo Dt, JM Vose and Kim Schmit-Pokorny and has published in prestigious journals such as Blood, Stem Cells and Bone Marrow Transplantation.

In The Last Decade

JO Armitage

42 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JO Armitage United States 24 1.3k 1.3k 1.3k 712 455 42 2.7k
J L Harousseau France 22 1.8k 1.3× 1.1k 0.9× 1.8k 1.4× 815 1.1× 397 0.9× 36 3.3k
B Desablens France 23 744 0.6× 854 0.6× 1.4k 1.1× 1.2k 1.7× 465 1.0× 89 2.6k
E Montserrat Spain 30 1.0k 0.8× 769 0.6× 1.8k 1.4× 1.4k 2.0× 820 1.8× 97 3.0k
Cesare Guglielmi Italy 24 1.8k 1.3× 1.4k 1.0× 2.3k 1.8× 1.3k 1.8× 638 1.4× 67 3.9k
Isabelle Plantier France 12 819 0.6× 843 0.6× 1.1k 0.8× 1.1k 1.6× 243 0.5× 22 2.2k
Françoise Rigal‐Huguet France 25 869 0.7× 1.3k 1.0× 1.0k 0.8× 837 1.2× 283 0.6× 66 2.7k
Meyer R. Heyman United States 14 1.1k 0.8× 436 0.3× 1.4k 1.1× 924 1.3× 699 1.5× 22 2.8k
R. Kuse Germany 26 734 0.5× 1.4k 1.1× 763 0.6× 703 1.0× 346 0.8× 78 2.4k
Réda Bouabdallah France 28 2.0k 1.5× 1.5k 1.1× 1.9k 1.5× 913 1.3× 577 1.3× 101 4.0k
Y Bastion France 23 1.6k 1.2× 373 0.3× 2.5k 1.9× 1.2k 1.7× 532 1.2× 47 3.2k

Countries citing papers authored by JO Armitage

Since Specialization
Citations

This map shows the geographic impact of JO Armitage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JO Armitage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JO Armitage more than expected).

Fields of papers citing papers by JO Armitage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JO Armitage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JO Armitage. The network helps show where JO Armitage may publish in the future.

Co-authorship network of co-authors of JO Armitage

This figure shows the co-authorship network connecting the top 25 collaborators of JO Armitage. A scholar is included among the top collaborators of JO Armitage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JO Armitage. JO Armitage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Armitage, JO, et al.. (2006). Lymphoma 2006: classification and treatment.. PubMed. 20(3). 231–9; discussion 242, 244, 249. 15 indexed citations
2.
Demirkazık, Ahmet, Anne Kessinger, JO Armitage, et al.. (2001). Progenitor and lymphoma cells in blood stem cell harvests: impact on survival following transplantation. Bone Marrow Transplantation. 28(2). 207–212. 20 indexed citations
3.
Armitage, JO, et al.. (1997). Complex partial status epilepticus after bone marrow transplantation for non-Hodgkin’s lymphoma. Bone Marrow Transplantation. 19(6). 637–638. 2 indexed citations
4.
Armitage, JO. (1992). Autologous bone marrow transplantation for patients with aggressive non-Hodgkin's lymphoma.. PubMed. 10 Suppl 1. 62–3. 8 indexed citations
5.
Vose, JM, PJ Bierman, JR Anderson, et al.. (1992). Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood. 80(8). 2142–2148. 111 indexed citations
6.
Vose, JM, PJ Bierman, JR Anderson, et al.. (1992). Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood. 80(8). 2142–2148. 113 indexed citations
7.
Warkentin, PI, DD Weisenburger, JM Vose, et al.. (1992). Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents. Blood. 80(11). 2938–2942. 19 indexed citations
8.
Sharp, J. Graham, JO Armitage, Philip J. Bierman, et al.. (1992). Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique. Blood. 79(4). 1074–1080. 99 indexed citations
9.
Vose, JM, Anne Kessinger, PJ Bierman, et al.. (1992). The use of rhIL-3 for mobilization of peripheral blood The International Journal of Cell Cloning in previously treated patients with lymphoid malignancies. Stem Cells. 10(S1). 62–64. 17 indexed citations
10.
11.
Kessinger, Anne & JO Armitage. (1991). The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies [editorial]. Blood. 77(2). 211–213. 173 indexed citations
12.
13.
Vose, JM, et al.. (1991). Familial haemophagocytic lymphohistiocytosis treated with allogeneic bone marrow transplantation.. PubMed. 7(2). 139–42. 38 indexed citations
14.
15.
Vose, JM, PJ Bierman, DD Weisenburger, et al.. (1990). Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas. Blood. 76(2). 424–431. 1 indexed citations
16.
Bierman, PJ, et al.. (1989). Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood. 74(7). 2579–2584. 83 indexed citations
17.
Armitage, JO. (1989). Bone marrow transplantation in the treatment of patients with lymphoma. Blood. 73(7). 1749–1758. 130 indexed citations
18.
19.
Weisenburger, DD, WG Sanger, JO Armitage, & Purtilo Dt. (1987). Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. Blood. 69(6). 1617–1621. 16 indexed citations
20.
Burns, CP, et al.. (1980). Prognostic influence of pretreatment characteristics in adult acute lymphoblastic leukemia. Blood. 56(3). 510–515. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J L Harousseau Breakdown of academic impact, for papers by B Desablens Breakdown of academic impact, for papers by E Montserrat Breakdown of academic impact, for papers by Cesare Guglielmi Breakdown of academic impact, for papers by Isabelle Plantier Breakdown of academic impact, for papers by Françoise Rigal‐Huguet Breakdown of academic impact, for papers by Meyer R. Heyman Breakdown of academic impact, for papers by R. Kuse Breakdown of academic impact, for papers by Réda Bouabdallah Breakdown of academic impact, for papers by Y Bastion
Rankless by CCL
2026